With out a doubt Orpahan drug status will be the best news, FDA approval to go ahead is expected anyway but orphan status is the biggy, it means many concessions both in cost and trial requirements.
Look for the sp to fly if CVac get the nod on this!
With out a doubt Orpahan drug status will be the best news, FDA...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $472.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.8¢ | 32.5¢ | $718.9K | 2.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 183899 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |